Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Rejuvenon
company
About
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $37M
- Industries
- Biotechnology,Developer Platform,Medical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$37M
Rejuvenon has raised a total of
$37M
in funding over 2 rounds. Their latest funding was raised on
Jun 23, 2004 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 23, 2004 | Series B | $37M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Rejuvenon is funded by 1 investors.
Cogene Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
